Institutional Fund
Spruce Street Capital LP
New York, NYCIK 20501942 filings on record
Portfolio Value
$415.94M
Q1 2026
Holdings
28
Reported positions
New Buys
7
Opened this quarter
QoQ Change
+37.4%
from $302.66M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Relmada Therapeutics Inc10.3%
- Kiniksa Pharmaceuticals Intl8.8%
- Lb Pharmaceuticals Inc8.1%
- Dianthus Therapeutics Inc7.5%
- Relay Therapeutics Inc7.1%
- Alto Neuroscience Inc7.0%
- Other51.1%
Portfolio Holdings
28 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Relmada Therapeutics Inc | 6.26M | $43.00M | 10.3% | +2.18M | Added |
| 2 | Kiniksa Pharmaceuticals Intl | 761.1K | $36.65M | 8.8% | +326.1K | Added |
| 3 | Lb Pharmaceuticals Inc | 1.38M | $33.64M | 8.1% | +370.6K | Added |
| 4 | Dianthus Therapeutics Inc | 373.3K | $31.33M | 7.5% | +75.8K | Added |
| 5 | Relay Therapeutics Inc | 2.98M | $29.69M | 7.1% | 0 | Held |
| 6 | Alto Neuroscience Inc | 1.33M | $29.12M | 7.0% | +1.10M | Added |
| 7 | Centessa Pharmaceuticals PLC | 489.8K | $19.46M | 4.7% | +411.9K | Added |
| 8 | Savara Inc | 3.38M | $18.47M | 4.4% | +972.1K | Added |
| 9 | Kalvista Pharmaceuticals Inc | 897.7K | $18.07M | 4.3% | +509.7K | Added |
| 10 | Vaxcyte Inc | 245.7K | $14.28M | 3.4% | −154.7K | Reduced |
18 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio